Clinical Trials
47
Active:3
Completed:30
Trial Phases
5 Phases
Phase 1:3
Phase 2:3
Phase 3:5
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Not Applicable
15 (48.4%)Phase 3
5 (16.1%)Phase 4
5 (16.1%)Phase 1
3 (9.7%)Phase 2
3 (9.7%)Protest Trial: TXA vs Saline
Phase 3
- Conditions
- Lung TransplantComplications Surgical
- Interventions
- Other: Saline (placebo)
- First Posted Date
- 2024-05-20
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Spectrum Health Hospitals
- Target Recruit Count
- 94
- Registration Number
- NCT06422273
- Locations
- 🇺🇸
Spectrum Health Hospitals, Grand Rapids, Michigan, United States
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
Not Applicable
Recruiting
- Conditions
- Malignant Gastric Outlet Obstruction
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Spectrum Health Hospitals
- Target Recruit Count
- 16
- Registration Number
- NCT05986890
- Locations
- 🇺🇸
G. Paul Wright, Grand Rapids, Michigan, United States
Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study
Terminated
- Conditions
- Heart Failure
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Spectrum Health Hospitals
- Target Recruit Count
- 371
- Registration Number
- NCT05637242
- Locations
- 🇺🇸
Frederik Meijer Heart Center, Grand Rapids, Michigan, United States
Intra-Corporeal Anastomosis Result in Quicker Return of Bowel Function/Earlier Discharge
Not Applicable
Recruiting
- Conditions
- Colorectal Disorders
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Spectrum Health Hospitals
- Target Recruit Count
- 125
- Registration Number
- NCT03862781
- Locations
- 🇺🇸
Spectrum Health Medical Group, Grand Rapids, Michigan, United States
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
Phase 2
Active, not recruiting
- Conditions
- Pancreatic AdenocarcinomaLiver Metastases
- Interventions
- First Posted Date
- 2019-02-27
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Spectrum Health Hospitals
- Target Recruit Count
- 14
- Registration Number
- NCT03856658
- Locations
- 🇺🇸
Spectrum Health, Grand Rapids, Michigan, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
News
No news found